After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, XENE falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Xenon Pharmaceuticals Inc is $2.85B. A total of 0.52 million shares were traded on the day, compared to an average of 440.58K shares.
In the most recent transaction, MORTIMER IAN sold 22,468 shares of XENE for 40.20 per share on Jan 24 ’25. After the transaction, the PRESIDENT & CEO now owns 31,302 company shares. In a previous transaction on Jan 27 ’25, MORTIMER IAN sold 16,315 shares at 40.50 per share. XENE shares that PRESIDENT & CEO owns now total 31,302.
Among the insiders who sold shares, MORTIMER IAN disposed of 16,217 shares on Jan 23 ’25 at a per-share price of $40.08. This resulted in the PRESIDENT & CEO holding 31,302 shares of XENE after the transaction. In another insider transaction, IAN MORTIMER bought 16,315 shares at $40.50 per share on Jan 27 ’25.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, XENE has a high of $47.44 and a low of $33.27.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. XENE’s latest balance sheet shows that the firm has $551.77M in Cash & Short Term Investments as of fiscal 2021. There were $8.26M in debt and $14.32M in liabilities at the time. Its Book Value Per Share was $9.88, while its Total Shareholder’s Equity was $550.03M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for XENE is Buy with a score of 4.88.
